Expert Outlook: AMETEK Through The Eyes Of 6 Analysts
6 analysts have shared their evaluations of AMETEK (NYSE:AME) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 3 | 2 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 1 | 3 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 0 | 0 |
Analysts have recently evaluated AMETEK and provided 12-month price targets. The average target is $207.5, accompanied by a high estimate of $225.00 and a low estimate of $190.00. This upward trend is evident, with the current average reflecting a 2.64% increase from the previous average price target of $202.17.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of AMETEK among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Richard Eastman | Baird | Raises | Neutral | $198.00 | $190.00 |
Matt Summerville | DA Davidson | Raises | Buy | $215.00 | $210.00 |
Brett Linzey | Mizuho | Raises | Outperform | $225.00 | $212.00 |
Deane Dray | RBC Capital | Raises | Outperform | $212.00 | $209.00 |
Steve Barger | Keybanc | Raises | Overweight | $205.00 | $195.00 |
Richard Eastman | Baird | Lowers | Neutral | $190.00 | $197.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to AMETEK. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of AMETEK compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for AMETEK's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of AMETEK's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on AMETEK analyst ratings.
Unveiling the Story Behind AMETEK
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.
A Deep Dive into AMETEK's Financials
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Positive Revenue Trend: Examining AMETEK's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 2.49% as of 30 June, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 20.16%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.52%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.38%, the company showcases effective utilization of assets.
Debt Management: AMETEK's debt-to-equity ratio is below the industry average. With a ratio of 0.19, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
The Significance of Analyst Ratings Explained
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Latest Ratings for AME
Date | Firm | Action | From | To |
---|---|---|---|---|
Jan 2022 | Morgan Stanley | Maintains | Overweight | |
Dec 2021 | Mizuho | Initiates Coverage On | Buy | |
Dec 2021 | Wolfe Research | Upgrades | Peer Perform | Outperform |
Posted-In: BZI-AARAnalyst Ratings